ArticleFrontiers in immunology2019

Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180.

Yosuke Mai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.